Augmentin for Post-D&C Prophylaxis: Not Recommended
Routine antibiotic prophylaxis with oral Augmentin (amoxicillin/clavulanate) is not recommended following outpatient dilation-and-curettage procedures. The highest quality evidence demonstrates no benefit in preventing post-procedural infection.
Evidence Base
The most recent and directly applicable guideline evidence comes from the 2024 RCOG Green-Top Guideline on outpatient hysteroscopy 1. This Level 1++ evidence from a large randomized controlled trial (n=1046 women) found that prophylactic antibiotics—including cefazolin (which has broader coverage than needed)—provided no significant reduction in post-procedural infection rates compared to placebo. The infection rate was extremely low in both groups: 1.0% with antibiotics versus 1.3% without (P > 0.05). All infections that did occur resolved completely with treatment antibiotics, and no patient developed upper genital tract or pelvic infection 1.
Why Prophylaxis Is Unnecessary
The baseline infection risk after gynecologic procedures like D&C is remarkably low (approximately 1%), making prophylactic antibiotics statistically ineffective and clinically unjustified. The guideline explicitly states: "Routine antibiotic prophylaxis is not recommended for outpatient hysteroscopic procedures" with Grade A strength (highest level) 1.
This recommendation aligns with antimicrobial stewardship principles. Augmentin (amoxicillin/clavulanate) is classified in the WHO AWaRe "Access" group 2, meaning it should be preserved for treatment of documented infections rather than squandered on unnecessary prophylaxis where no benefit exists.
When Antibiotics ARE Indicated
The evidence is clear about when antibiotics matter in gynecologic surgery:
- Cesarean section: Cefazolin 2g IV pre-incision is standard, with azithromycin added for unscheduled procedures 3
- Procedures with prosthetic material: Prophylaxis is indicated 4
- Documented infection: Treat with appropriate antibiotics when infection criteria are met 1
For D&C specifically, there is no evidence supporting prophylaxis in any guideline reviewed.
Clinical Pitfalls to Avoid
Do not confuse treatment with prophylaxis: If a patient develops fever, pelvic pain, or purulent discharge post-D&C, this requires therapeutic antibiotics—not prophylactic ones given beforehand 1
Avoid "just in case" prescribing: The infection rate is so low (1%) that treating 100 patients prophylactically to potentially prevent 0-1 infection is poor stewardship and exposes 99+ patients to unnecessary antibiotic side effects 1
Recognize that oral Augmentin has no role here: Even if prophylaxis were indicated (which it is not), the timing and route would be wrong. Surgical prophylaxis requires IV administration 30-60 minutes pre-incision to achieve adequate tissue levels 4. Oral outpatient prescriptions given post-procedure miss this critical window entirely.
The Bottom Line
Skip the Augmentin prescription after outpatient D&C. The evidence unequivocally shows no benefit, and prescribing it violates antimicrobial stewardship principles while exposing patients to unnecessary medication risks (GI upset, C. difficile, allergic reactions) 5. Reserve antibiotics for the rare patient who develops documented post-procedural infection, where treatment—not prophylaxis—is appropriate and effective 1.